The cellular prion protein (PrPC) as neuronal receptor for α-synuclein
- PMID: 28759332
- PMCID: PMC5553301
- DOI: 10.1080/19336896.2017.1334748
The cellular prion protein (PrPC) as neuronal receptor for α-synuclein
Abstract
The term 'prion-like' is used to define some misfolded protein species that propagate intercellularly, triggering protein aggregation in recipient cells. For cell binding, both direct plasma membrane interaction and membrane receptors have been described for particular amyloids. In this respect, emerging evidence demonstrates that several β-sheet enriched proteins can bind to the cellular prion protein (PrPC). Among other interactions, the physiological relevance of the binding between β-amyloid and PrPC has been a relevant focus of numerous studies. At the molecular level, published data point to the second charged cluster domain of the PrPC molecule as the relevant binding domain of the β-amyloid/PrPC interaction. In addition to β-amyloid, participation of PrPC in binding α-synuclein, responsible for neurodegenerative synucleopathies, has been reported. Although results indicate relevant participation of PrPC in the spreading of α-synuclein in living mice, the physiological relevance of the interaction remains elusive. In this comment, we focus our attention on summarizing current knowledge of PrPC as a receptor for amyloid proteins and its physiological significance, with particular focus on α-synuclein.
Keywords: LAG3; Parkinson disease; PrPC; charged cluster domain; interneuronal transport; neurodegeneration; α-synuclein.
Figures
 
              
              
              
              
                
                
                Comment on
- Extra View to: Urrea L, Segura-Feliu M, Masuda-Suzukake M, Hervera A, Pedraz L, García Aznar JM, Vila M, Samitier J, Torrents E, Ferrer I, et al. Involvement of cellular prion protein in α-synuclein transport in neurons. Mol Neurobiol 2017; [epublished ahead of print]; https://doi.org/10.1007/s12035-017-0451-4
References
- 
    - Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003; 39:889-909; PMID:12971891 - PubMed
 
- 
    - Lowe J, Blanchard A, Morrell K, Lennox G, Reynolds L, Billett M, Landon M, Mayer RJ. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 1988; 155:9-15; PMID:2837558; https://doi.org/10.1002/path.1711550105 - DOI - PubMed
 
- 
    - Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 2003; 62:389-97; PMID:12722831 - PubMed
 
- 
    - Noda K, Kitami T, Gai WP, Chegini F, Jensen PH, Fujimura T, Murayama K, Tanaka K, Mizuno Y, Hattori N. Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease. Biochem Biophys Res Commun 2005; 331:309-17; PMID:15845394; https://doi.org/10.1016/j.bbrc.2005.03.167 - DOI - PubMed
 
- 
    - Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839-40; PMID:9278044; https://doi.org/10.1038/42166 - DOI - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Research Materials
 
        